At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CDIO CARDIO DIAGNOSTICS HOLDINGS INC
Trading 12-27 14:56:20 EST
0.9344
-0.0459
-4.68%
High1.00
Low0.9003
Vol1.11M
Open1.00
D1 Closing0.9803
Amplitude10.17%
Mkt Cap37.79M
Tradable Cap32.82M
Total Shares40.44M
T/O1.03M
T/O Rate3.16%
Tradable Shares35.13M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Cardio Diagnostics Holdings, Inc. (CDIO) Secures Medicare Pricing Approval for Precision Cardiovascular Tests
Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination From Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests
Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests
Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests
Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.